RESEARCH at PCC
PCC has been supporting high-quality, high-impact, novel research since 2009, and continues to budget approximately US$2.0M annually to support scientific studies that are likely to generate methods or products that will contribute to and improve the anti-doping landscape.
The SCIENTIFIC RESEARCH PROGRAM represents PCC's primary core business activity, promoting original work that focuses on improving existing analytical methods for detecting particular drugs, developing analytical methods to test for substances not currently detectable, and discovering cost effective approaches for testing widely abused substances across all levels of sport. The SCIENTIFIC RESEARCH PROGRAM is open to scientists and researchers worldwide and runs three times per year, with each round of proposals reviewed by a panel of established and highly respected experts. Individual grant awards have ranged from US$60,000 to US$400,000+ with a turnaround time on awards averaging less than four months.
The following areas of investigation are related directly to the mission of the Corporation and reflect (but are not listed in order of and are exemplary not all inclusive) its potential research priority interests:
- Developing methods of cost effective testing to detect and deter the use of banned and illegal substances at that may be utilized by colleges, high schools and youth sports associations, among others;
- Developing testing protocols to detect designer substances used for doping purposes;
- Research into a widely-available, cost-effective test for detecting Human Growth Hormone (HGH)
- Developing an athlete passport system which utilizes longitudinal data
- Exploring the uses of banned substances and the societal causes of the uses of such substances.
- Improving existing analytical methods to detect particular drugs, e.g.,: GH, IGF-1, EPO, hCG , discrimination of exogenous and endogenous steroids , screening methods for common steroids, stimulants.
- Developing analytical methods to detect performance enhancing drugs not currently detectable, e.g.,: Selective Androgen Receptor Modulators , identifying designer steroids, autologous blood transfusions, other forms of enhanced oxygen transport and use.
- Discovering cost effective approaches for testing widely abused substance
- Longitudinal studies to document urinary excretion patterns, metabolism and dose-concentration
- Critical Reviews of the literature from which to develop Position Papers to support interpretation of laboratory data
- Alternative specimens, (e.g., hair, sweat, saliva, interstitial fluid) for testingBetter understanding of how banned substances are used and the implications for the long-term health consequences of athletes
APPLYING for a PCC GRANT
PCC runs a two-step grant application process, three times per year:
Step I: PRE-application (open, see deadlines below)
Step II: FULL application (by invitation only)
PCC reviews PRE-applications on a rolling basis. Applicants whose pre-applications align with PCC research objectives and show considerable potential are then invited to submit full grant applications.
- R1 PRE-applications due March 1 R1 FULL applications due April 1
- R2 PRE-applications due July 1 R2 FULL applications due August 1
- R3 PRE-applications due November 1 R3 FULL applications due December 1